Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisRobert Zivadinov, Omar Khan, Anthony T. Reder et al.|Neurology|2008Cited by 261
Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patientsRalph H. B. Benedict, Robert Zivadinov, Hanneke E. Hulst et al.|Multiple Sclerosis Journal|2013Cited by 104
2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosisFrederik Barkhof, Àlex Rovira, Michael G. Dwyer et al.|The Lancet Neurology|2025Cited by 64
Cognitive progression independent of relapse in multiple sclerosisTom Fuchs, Ralph H. B. Benedict, Menno M. Schoonheim et al.|Multiple Sclerosis Journal|2024Cited by 34
Functional network dynamics and decreased conscientiousness in multiple sclerosisTom Fuchs, Ralph H. B. Benedict, Menno M. Schoonheim et al.|Journal of Neurology|2021Cited by 19